Article
Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells
26 Jul 2012
Abstract excerpt
The production of human induced pluripotent stem cells (hiPSCs) has greatly expanded the realm of possible stem cell-based regenerative medicine therapies and has particularly exciting potential for autologous therapies. However, future therapies based on hiPSCs will first have to address not only similar regulatory issues as those facing human embryonic stem cells with the US FDA and international regulatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
